focus -WSS

focus

author：comprehensive 2025-09-27 09:58:01 - browse：4

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Trump indictment: Who are the 'co

Wikipedia

WSS

No plane should take off without an EpiPen onboard

Tuberculosis patients need more than just free medication

Trump used to be more articulate. What could explain the change?

NFL doctors' conflicts of interest could endanger players, report says

Physician groups backed by private equity giant lobby on mergers

It was time to plan for my old age. If only I could stop crying

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Election results set back Medicaid expansion plans

Supreme Court strikes down use of affirmative action

'Brian's Song' at 50 still offers lessons about cancer for today

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Adults seen as increasingly susceptible to measles

Trump demands the U.S. pay no more for drugs than other countries … again

Pennsylvania man bitten on the head by bear during attack in his garage

The high cost of giving birth even with insurance

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

entertainment

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Doctors are clamoring for more clarity on Paxlovid prescribing

Judge in Trump's classified documents case questions use of out

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Election results set back Medicaid expansion plans

Adults seen as increasingly susceptible to measles

focus

Wikipedia

hotspot

leisure time